Skip to main content

Mintz Member Terri Shieh-Newton Featured Among Pioneers in Science Speaking at SynBioBeta 2019

Mintz Member Terri Shieh-Newton, PhD, will participate on a panel of esteemed women leaders in science and, separately, present a featured talk during SynBioBeta 2019–The Global Synthetic Biology Summit–taking place October 1-3 in San Francisco.

SynBioBeta 2019 will bring together entrepreneurs, academics, investors, and thought-leaders committed to advancing biological engineering and showcase cutting-edge synthetic biology research and technologies. Mintz is proud to serve as a Bronze-level sponsor of the conference.

Dr. Shieh-Newton will participate in a Women’s Luncheon on October 2, featuring fellow panelists:

  • Frances Arnold, Nobel Laureate, Linus Pauling Professor of Chemical Engineering, Bioengineering and Biochemistry and Director of the Rosen Bioengineering Center at the California Institute of Technology;
  • Dr. Una Ryan, Founder of ULUX LLC, a science-to-art company exploring the unity of intracellular and extraterrestrial spaces; and
  • Rosalind Franklin, Principal at Rosalind Franklin Group, and a Certified Professional Coach and Consultant.

These four women represent pioneers in science and support the industry through leadership and mentorship. During the event, panelists will share their views on the future of synthetic biology, and how attendees can support women-led initiatives in that space.

Separately, on October 3, Dr. Shieh-Newton will present a featured talk titled “Legal Considerations for Using AI in Synthetic Biology.”

Dr. Shieh-Newton plays a strategic role for her clients as she guides their portfolio management and performs sophisticated landscape analyses. Trained as an immunologist at Johns Hopkins, where she earned a PhD in Cellular and Molecular Medicine, she works with companies of all sizes in a wide range of life sciences and clean technology industries. She also manages and conducts due diligence for companies and investors. Dr. Shieh-Newton is known for her creative, business-savvy solutions and collaborative work style.

SynBioBeta is the leading community of entrepreneurs, investors, policymakers and enthusiasts devoted to the responsible growth of the synthetic biology field.

For more information on SynBioBeta 2019, please visit

For more information about Mintz, please visit